ROME, ITALY — Using the factor Xa inhibitor edoxaban (Savaysa/Lixiana, Daiichi Sankyo) to anticoagulate patients about to undergo electrical cardioversion for their atrial fibrillation (AF) seems ...

A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial ...

Medtronic alerted healthcare professionals in Europe to the risk of cardioversion-related damage to the Vanta implantable neurostimulator (INS), model 977006, During cardioversion, healthcare workers ...

I recently diagnosed atrial fibrillation in a 24-year-old man with new-onset chest pain, irregular palpitations, and heart rate >170 beats per minute. The patient has no history of drug or tobacco ...

The Vanta device by Medtronic plc, provides relief from pain for thousands of patients, but the Vanta might also feel the pain when the patient is undergoing cardioversion. According to a field safety ...

Medtronic has warned that one of the models in its Vanta range of implantable neurostimulators for pain relief may stop working if the patient is given cardioversion therapy to restore a normal heart ...

ESC ENSURE-AF: Edoxaban Effective as Warfarin at AF Cardioversion "If you've got a patient on edoxaban coming in for cardioversion, do you need to switch him over to warfarin, or is it safe to carry ...

A cup of caffeinated coffee each day may lower the risk of an irregular heart rhythm coming back after treatment. That is the ...